Pay in 4 interest-free payments of $7.01 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Nothing in this article constitutes a claim that any compounded product is clinically proven, has been evaluated in clinical trials, or produces the same results as any FDA-approved drug
Injections can still be considered in specific circumstances, such as when a neurological or haematological condition could deteriorate rapidly, or when there are serious concerns that oral treatment will not be taken reliably
No freezing reconstituted peptides causes ice crystal formation that physically shears peptide chains, resulting in irreversible denaturation
PubChem compound record PubChem
Study limitations included the lack of generalizability to patients in later stages of ALS, risk of including ALS mimics, shorter treatment duration of 16 weeks vs the typical 24 weeks in other clinical trials, small sample size, and lack of evaluation of specific disease-related biomarkers
US$ 28.14
US$ 20.74
US$ 28.82
US$ 26.66
